Kenneth I. Kohn
10Patents
2h-index
7Co-inventors
39Inventor score
Filing activity: Jan 4, 2013 → Oct 5, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11491207B2 | Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy | Emerging Cross-Sectional Technologies | 4 | Active |
| US9867842B2 | Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage | Human Necessities | 2 | Active |
| US12009109B2 | Smart dosing for cancer therapy | Physics | 1 | Active |
| US12293815B2 | Smart multidosing | Emerging Cross-Sectional Technologies | 0 | Active |
| US12205705B2 | Smart nutrition dosing | Physics | 0 | Active |
| US9545415B2 | Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation | Human Necessities | 0 | Active |
| US10279014B2 | Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy | Emerging Cross-Sectional Technologies | 0 | Active |
| US9925204B2 | Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation | Human Necessities | 0 | Active |
| US12300370B2 | Smart dosing for cancer therapy | Physics | 0 | Active |
| US12347538B2 | Smart multidosing | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.